Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
Lee HC et al. | 2015 | intact cell/cell culture, MCF10 A (human breast epithelial cell line), MCF7 (human breast cancer cell line), Jurkat cells (human lymphoblastoid T cell line), NIH3T3 (mouse embryonic fibroblast cell line) | magnetic field, 50/60 Hz | 0.1–2 mT |
Elexpuru-Zabaleta M et al. | 2023 | intact cell/cell culture, MDA-MB-231 and MCF-7 (breast cancer cell lines) and MCF-10A (breast cell line) | magnetic field, 50/60 Hz | - |
Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
Shoorche AB et al. | 2023 | intact cell/cell culture, MG-63 cells (human osteosarcoma cell line) | magnetic field, low frequency, 50/60 Hz, signals/pulses | - |
Lekovic MH et al. | 2020 | intact cell/cell culture, MRC-5 (human diploid fibroblasts) | 50/60 Hz, magnetic field | 10 mT |
Martinez MA et al. | 2012 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz | 100 µT |
Martinez MA et al. | 2016 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Martínez MA et al. | 2019 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | 100 µT |
Trillo MA et al. | 2013 | intact cell/cell culture, NB69 cells (neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 10–100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.